Searched for
UNLOXCYT APPROVAL
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Sun Pharma Q3 profit jumps 16% YoY as branded and innovative businesses drive growthSun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth w...
- New launches and R&D pipeline bolster Sun Pharma's long-term growth outlookSun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launch...
- Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on marginsSun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi la...
- Sun Pharma lines up $100 mn to commercialise niche products this fiscalSun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, focusing on its spe...
- I-Sec upgrades Sun Pharma to Buy, target price Rs 1,895ICICI Securities has upgraded Sun Pharmaceutical Industries to 'Buy' with a revised target price of Rs 1895. Sun Pharma, a leading company ...
- Stocks to buy today: IndusInd Bank gets a downgrade; Motilal Oswal sees over 20% upside in Sun PharmaNuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while Antique remai...
- Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 millionSun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal invo...
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mnSun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for advanced cuta...
Load More
